Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis

Nutrition in Clinical Practice

Volumn 26, Issue 6, 2011, Pages 665-671

  Sungurtekin, Hulya ^a   Deǧirmenci, Sezai ^a   Sungurtekin, Ugur ^a   Oguz, Berna Elibol ^a   Sabir, Nuran ^a   Kaptanoglu, Bunyamin ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

cytokines; fat emulsions, intravenous; fatty liver; fish oils; parenteral nutrition; sepsis; systemic inflammatory response syndrome

Indexed keywords

FISH OIL; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPID EMULSION; LIPOFUNDIN; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; OMEGA 3 FATTY ACID; OMEGAVEN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; APACHE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY LIVER; FEMALE; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE UNIT; LIVER PROTECTION; MALE; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULTRASOUND;

ADULT; AGED; APACHE; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; FATTY LIVER; FEMALE; FISH OILS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855169276     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611418783     Document Type: Article

References (30)

1. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol. 2008 ; 24 (2). 215-222 (Pubitemid 351322790)
2. Furst P, Kuhn KS. Fish oil emulsions: what benefits can they bring?. Clin Nutr. 2000 ; 19: 7-14 (Pubitemid 30150803)
3. Calder PC. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc. 2009 ; 68: 252-260
4. Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology. 1999 ; 96: 404-410 (Pubitemid 29118328)
5. Vermillion SE, Gregg JA, Baggenstoss AH, Bartholomew LG. Jaundice associated with bacteremia. Arch Intern Med. 1969 ; 124: 611-618
6. Pastor CM, Billiar TR, Losser MR, Payen DM. Liver injury during sepsis. J Crit Care. 1995 ; 10: 183-197 (Pubitemid 26004512)
7. Koskinas J, Gomatos IP, Tiniakos DG. Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol. 2008 ; 14 (9). 1389-1393 (Pubitemid 351425219)
8. Ludwig J, Batts KP Practical Liver Biopsy Interpretation: Diagnostic Algorithms. 2 nd ed.Chicago: ASCP Press; 1998:53-54. Chicago: ASCP Press ; 1998: 53-54.
9. Alwayn IP, Gura K, Nose V. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 ; 57: 445-452 (Pubitemid 40293615)
10. Alwayn IP, Andersson C, Zauscher B. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation. 2005 ; 79: 606-608 (Pubitemid 40365891)
11. Yeh SL, Chang KY, Huang PC, Chen WJ. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition. 1997 ; 13: 32-36 (Pubitemid 27098611)
12. Araya J, Rodrigo R, Videla LA, et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with nonalcoholic fatty liver disease. Clin Sci (Lond). 2004 ; 106: 635-643 (Pubitemid 38797577)
13. Wilson SR, Rosen IE, Chin-Sang HB, Arenson AM. Fatty infiltration of the liver: an imaging challenge. J Can Assoc Radiol. 1982 ; 33 (4). 227-232 (Pubitemid 13068958)
14. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003 ; 31 (4). 1250-1256 (Pubitemid 36444440)
15. Mayer K, Gokorsch S, Fegbeutel C, Hattar K. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003 ; 167 (10). 1321-1328 (Pubitemid 36609714)
16. Wang X, Li W, Li N, Li J. ω 3 Fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr. 2008 ; 32: 236-241 (Pubitemid 351571258)
17. Madeleine JB. Hematological and biochemical effects of parenteral nutrition with medium-chain triglycerides: comparison with long-chain triglycerides. Am Soc Clin Nutr. 1991 ; 53: 916-922
18. Mayer K, Fegbeutel C, Hattar K, et al. ω-3 vs. ω-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 2003 ; 29: 1472-1481 (Pubitemid 37153591)
19. Reimund JM, Arondel Y, Joly F, Messing B, Duclos B, Baumann R. Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease. Clin Nutr. 2004 ; 23: 1418-1425 (Pubitemid 39517636)
20. Weiss G, Meyer F, Matthies B, Pross M, Koenig W, Lippert H. Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr. 2002 ; 87: S89 - S94
21. Wachtler P, Konig W, Senkal M, Kemen M, Koller M. Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma. 1997 ; 42: 191-198 (Pubitemid 27104652)
22. Heller AR, Rossler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006 ; 34: 972-979
23. Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med. 2008 ; 34: 1411-1420
24. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010 ; 145 (6). 547-551
25. Kelly DA. Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition. 1998 ; 14 (1). 153-157 (Pubitemid 28049003)
26. Zaman N, Tam YK, Jewell LD, Coutts RT. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos. 1997 ; 18 (9). 803-819 (Pubitemid 27517569)
27. Alfin-Slater RB, Aftergood L. Essential fatty acids reinvestigated. Physiol Rev. 1968 ; 48: 758-784
28. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 ; 118 (1). 197-201
29. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250 (3). 395-402
30. de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 ; 50 (2). 212-218